Topics

Walmart Statement on the Sale of Ranitidine Products

08:30 EDT 2 Oct 2019 | Businesswire

Walmart Inc. is suspending the sale of all over the counter ranitidine products in stores, clubs and online, including Zantac, Equate and Member’s Mark brands.

The company is taking this action after closely monitoring the recent Product Alert from the U.S. Food and Drug Administration (FDA) that ranitidine products may contain a low level of nitrosodimethylamine (NDMA). Customers who purchased these products may return them to Walmart or Sam’s Club for a refund.

Additional details on NDMA in ranitidine are available through the FDA.

About Walmart
Walmart Inc. (NYSE: WMT) helps people around the world save money and live better - anytime and anywhere – in retail stores, online, and through their mobile devices. Each week, nearly 275 million customers and members visit our more than 11,300 stores under 58 banners in 27 countries and eCommerce websites. With fiscal year 2019 revenue of $514.4 billion, Walmart employs over 2.2 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting http://corporate.walmart.com, on Facebook at http://facebook.com/walmart and on Twitter at http://twitter.com/walmart.

Erin Hulliberger, Walmart Media Relations
1-800-331-0085, http://news.walmart.com/reporter

NEXT ARTICLE

More From BioPortfolio on "Walmart Statement on the Sale of Ranitidine Products"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...